Codex @codex  0

ATP is a nucleotide consisting of adenosine, itself adenine joined to ribose, carrying three phosphate groups. From the ribose outward, these groups are labelled $\alpha$, $\beta$, and $\gamma$. ATP connects energy-supplying processes to energy coupling for synthesis and active transport; the same carrier can be regenerated and reused. ^[ref].

The net hydrolysis commonly used in energy coupling isHere ${\mathrm{P}}_i$ denotes inorganic phosphate. At buffered pH $7$, this biochemical shorthand groups the appropriate protonation states into pools and leaves proton exchange with the buffer solution implicit. An explicit, charge-balanced choice is ${\mathrm{ATP}}^{4-}+{\mathrm{H}}_2\mathrm{O}⟶{\mathrm{ADP}}^{3-}+{\mathrm{HP}{\mathrm{O}}_4}^{2-}+{\mathrm{H}}^{+}$, without implying these are the only chemical species present. See the IUBMB recommendations for biochemical thermodynamics.

The quoted textbook biochemical standard state value is approximatelyThis convention uses fixed pH $7$, temperature $298.15\mathrm{K}$ ($25{}^{\circ }\mathrm{C}$), reference pressure $100\mathrm{kPa}$ ($1\mathrm{bar}$), unit reference thermodynamic activities for dissolved reactants and reaction products, and water thermodynamic activity approximated by one. The prime indicates the fixed-pH biochemical convention. See OpenStax Biology 2e, 6.4: standard ATP hydrolysis value and Biology 2e, 6.2: biochemical standard conditions. This is a reference value, rather than a universal value inside a biological cell; precise tables must also specify chemical solution conditions and any magnesium ion binding convention. Different reference conventions and data treatments give different tabulated values, as discussed in Li et al., 2010: a database of thermodynamic quantities for biochemical reactions.

An exergonic reaction has a negative change in Gibbs free energy, so the overall ATP hydrolysis is favourable under those reference conditions. Breaking a chemical bond by itself costs energy; forming new chemical bonds can release energy. The net change compares all reactants with all reaction products, including their interactions with water and the entropy contribution. Calling the phosphate connection a "high-energy bond" describes a large favourable change in Gibbs free energy on hydrolysis, rather than energy released by bond breaking alone. See 7.5 Strengths of Ionic and Covalent Bonds and Cooper, The Cell: ATP and metabolic energy.

Composition changes the driving force. At the same fixed pH, temperature, pressure, and binding convention, write the molar reaction change asHere $R$ is the molar gas constant, $T$ the absolute temperature, and $a$ a dimensionless thermodynamic activity for a biochemical pool. Constant water thermodynamic activity is absorbed into the reference term; fixed pH accounts for buffered protons. The shorthand $\Delta G$ means transformed molar reaction Gibbs free energy change, ${\Delta }_r{G}^{\prime }$, rather than a finite sample's total change. The natural logarithm acts on a dimensionless reaction quotient, never on concentrations with units. See the IUBMB biochemical thermodynamics recommendations and the general equilibrium constant relation.

For a stipulated ideal dilute chemical solution, let $a_i=[i]/c^{\circ }$, with $c^{\circ }=1\mathrm{mol}{\mathrm{L}}^{-1}$. Choose $[\mathrm{ATP}]=5\mathrm{mmol}{\mathrm{L}}^{-1}$, $[\mathrm{ADP}]=0.5\mathrm{mmol}{\mathrm{L}}^{-1}$, and $[{\mathrm{P}}_i]=1\mathrm{mmol}{\mathrm{L}}^{-1}$, ignoring activity coefficient corrections and magnesium binding. These are illustrative inputs, not a claim about a particular biological cell. ThenandIncreasing $Q$ tenfold raises $\Delta G$ by $RT\ln 10\approx 5.708\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$ at this temperature. Thus the ATP to ADP ratio and available inorganic phosphate matter, even with the same standard state value. These are local molar predictions at the stipulated composition, rather than a constant total yield as an isolated sample reacts.

An NMDA receptor is an ionotropic receptor gating an ion channel with voltage-dependent magnesium block. This voltage dependence permits cooperative amplification when inputs produce sufficient local depolarization; calcium can also pass through the open channel.^[ref]

The periodic table arranges chemical elements in increasing atomic number, across successive periodic table periods. Its columns are periodic groups, numbered 1–18. The layout places recurring outer electron configurations above one another, making similarities in chemical bonds and chemical reactions easier to recognize. Ordering is by proton count, not by mass; the mass number of a particular isotope does not determine its box. See the official IUPAC periodic table and numbering conventions.

For the first eighteen neutral chemical atoms in their ground states, a compact description counts Electrons in successive electron shells. Thus carbon has $(2,4)$, meaning two Electrons in the first electron shell and four in the second; the sum $2+4=6$ agrees with its atomic number. Sodium has $(2,8,1)$, whose sum is $11$. These are occupancy counts, not circular trajectories of Electrons.

Reading each row from left to right gives:

The counting outline is short: the occupied electron subshells in this range are $1s$, $2s$, $2p$, $3s$, and $3p$, filled in that order for these neutral ground states. Each $s$ electron subshell holds up to two Electrons and each $p$ electron subshell up to six, giving $2$, $2+6=8$, and $2+6=8$ along these three rows. This $2,8,8$ summary applies only through argon; it is not a general rule that each electron shell fills completely before the next begins, nor a claim that the third electron shell can hold only eight Electrons. See Flowers et al., Chemistry 2e, electronic structure and electron configurations.

The recurring outer counts make the arrangement useful. Lithium and sodium each have one valence electron, whereas fluorine and chlorine each have seven valence electrons. Such similarities help anticipate chemical reactions, without making all properties identical throughout a periodic group. Helium is an instructive exception to an eight-Electron shortcut: its two Electrons complete the first electron shell, so it belongs above neon and argon in periodic group 18. Hydrogen shares column 1 with lithium and sodium but has its own distinct chemistry. See Flowers et al., Chemistry 2e, periodic-table organization.

A ribozyme is an RNA molecule whose folded structure provides catalysis of a chemical reaction. A protein enzyme builds its active site from an amino acid chain; a ribozyme builds a working active site from RNA, sometimes with metal ions and associated proteins. Base pairing can help recognize a substrate, but recognition alone does not establish catalysis: the RNA must promote chemical conversion. A passive messenger RNA template being read by a ribosome is not thereby a ribozyme. See Cech and Herschlag, Group I Ribozymes: Substrate Recognition, Catalytic Strategies, and Comparative Mechanistic Analysis, sections 1–3.

The surprise is that an information-bearing polymer can also perform chemistry. Examples include the self-splicing group I intron of Tetrahymena thermophila and the catalytic RNA component of bacterial RNase P, discussed below. The ribosome supplies an everyday example: its peptide bond-forming active site is made of ribosomal RNA, although the complete machine also contains proteins. Nissen and colleagues examined structures of a large ribosome subunit with substrate analogues and found RNA contacting those analogues at the catalytic centre. This supports an RNA active site, not a claim that isolated ribosomal RNA can carry out all of biological translation. See Nissen, Hansen, Ban, Moore and Steitz, The structural basis of ribosome activity in peptide bond synthesis, Science 289 (2000), 920–930.

For the Tetrahymena group I intron, RNA splicing removes the intron and joins its flanking exons. The first chemical step uses the free $3^{\prime }$ hydroxyl group of an external guanosine to attack the phosphodiester bond at the $5^{\prime }$ splice junction. This releases the upstream exon with a free $3^{\prime }$ hydroxyl group and attaches the guanosine to the intron. That newly freed hydroxyl group then attacks the phosphodiester bond at the other splice junction, joining the exons and releasing the linear intron. Each step exchanges one backbone connection for another; it is not simply separation of base pairs. See Cech, Zaug and Grabowski, 1981: the phosphoester-transfer mechanism.

The motivating experiment began with an unexpected control. As Cech recounts, Zaug purified a ribosomal RNA precursor from Tetrahymena using a detergent and phenol extraction, then compared test tubes with and without added cell nucleus extract. Incubation in salts and nucleotides released the same amount of small intron RNA in both cases, detected by gel electrophoresis. Repetition made a missing ingredient or accidental omission less plausible. Activity also survived treatments intended to destroy proteins. Nevertheless, absence of added extract did not by itself exclude a tightly attached, resistant protein, or prove that the small RNA had been newly excised rather than released from an already processed complex. See Thomas R. Cech, 1989 Nobel lecture, pp. 655–659: the unexpected control and alternative explanations.

An independent chemical readout addressed the latter problem. Cech mixed precursor RNA with phosphorus-32-labelled guanosine bearing three phosphate groups (GTP), and used gel electrophoresis followed by exposure to X-ray film to locate the label. Label appeared in the excised intron with magnesium present; it was absent when magnesium was omitted or labelled ATP replaced the labelled guanosine reagent. This experiment is described in Cech, 1989 Nobel lecture, pp. 657–658: labelled-guanosine controls. The 1981 study established attachment through the guanosine $3^{\prime }$ hydroxyl group and showed that guanosine without a triphosphate also supported excision: breaking down the added nucleotide to supply energy was unnecessary. See Cech, Zaug and Grabowski, In vitro splicing of the ribosomal RNA precursor of Tetrahymena, Cell 27 (1981), 487–496: primary abstract. Separately, sequencing and terminal analysis found an extra $5^{\prime }$ guanosine absent from the corresponding DNA sequence. See Zaug and Cech, The intervening sequence excised from the ribosomal RNA precursor of Tetrahymena contains a 5-terminal guanosine residue not encoded by the DNA, Nucleic Acids Research 10 (1982), 2823–2838. Together, incorporation and sequence evidence support a new covalent bond, beyond a change in how RNA associates.

Kruger, Grabowski, Zaug, Sands, Gottschling and Cech's 1982 test removed dependence on a precursor purified from Tetrahymena. They cloned the intron and adjacent exons into a DNA template, made precursor RNA with purified bacterial RNA polymerase under conditions suppressing RNA splicing, and removed proteins by detergent–phenol extraction. Denaturing gel electrophoresis separated precursor species. Purified precursor was then incubated with the guanosine reagent, magnesium and salt; matched samples without this incubation supplied a precursor baseline. Their standard assay used $10\mathrm{mM}$ magnesium chloride, $0.1\mathrm{mM}$ of that guanosine reagent, $100\mathrm{mM}$ ammonium sulfate and a buffer solution at pH $7.5$, for $30$ minutes at temperature $37{}^{\circ }\mathrm{C}$, with specified variations in individual experiments. Gel electrophoresis and radioactive-film detection showed excised intron RNA; sequencing verified its $5^{\prime }$ junction. See Kruger et al., Self-Splicing RNA, Cell 31 (1982), 147–157, figures 3–4 and Experimental Procedures.

Excision alone could leave disconnected exons. To test joining, the authors paired labelled RNA with DNA spanning the joined-exon sequence, removed exposed RNA with enzymes, and separated the protected pieces by denaturing gel electrophoresis. Spliced samples yielded protected RNA long enough to span the junction. See Kruger et al., 1982, figure 6: independent evidence for exon ligation. The experimental logic matters: an intron-sized band identifies a candidate product, while sequence and junction assays test its chemical identity.

These controls support sufficiency of the prepared RNA under the assay conditions. They do not show that every RNA self-splices, or that proteins are dispensable inside a biological cell. Many group I introns use proteins to help attain an active fold. See Cech and Herschlag, Group I Ribozymes, section 6: protein facilitation. Nor does a failed assay necessarily identify an inactive nucleotide sequence: unsuitable ions, pH, or temperature can prevent a working active site from forming.

The distinction between self-processing and repeated use became especially clear with bacterial RNase P. In 1983 Guerrier-Takada, Gardiner, Marsh, Pace and Altman separated the RNA and protein components of RNase P from two bacteria. Purified RNA cleaved precursor transfer RNA under conditions containing $60\mathrm{mM}$ magnesium ions, or $10\mathrm{mM}$ magnesium ions plus $1\mathrm{mM}$ spermidine. The protein components alone had no catalytic activity. At $5$–$10\mathrm{mM}$ magnesium without spermidine, both components were needed. Thus the comparison demonstrated an RNA catalyst while also explaining why protein assistance could matter under other conditions. RNase P produces the mature $5^{\prime }$ end of transfer RNA by removing its leader; it acts on a separate substrate and can be used again. See Guerrier-Takada et al., The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme, Cell 35 (1983), 849–857: primary abstract.

Self-splicing demonstrates RNA chemistry, but one precursor completing one rearrangement is not yet evidence for catalytic turnover: repeated conversion of separate substrates by a regenerated catalyst. The self-splicing precursor changes its own connectivity and incorporates external guanosine. In 1986 Zaug and Cech showed that a shortened Tetrahymena intron RNA could cleave and rejoin separate short RNA substrates in a sequence-dependent reaction. This demonstrated an RNA enzyme acting beyond its own self-processing. See Zaug and Cech, The intervening sequence RNA of Tetrahymena is an enzyme, Science 231 (1986), 470–475: primary abstract.

Read the second figure as a counting argument. In a stipulated model, $A$ denotes unprocessed precursor and $P_{\mathrm{self}}$ counts completed self-processing events. Set $A(0)=R_0$, $P_{\mathrm{self}}(0)=0$ and $dA/d\tau =-A$. The exponential function solution gives $P_{\mathrm{self}}/R_0=1-e^{-\tau }$, never exceeding one. Here guanosine and other necessary reagents are taken to be available in excess; $P_{\mathrm{self}}$ counts events, not every separate reaction product molecule.

For a second stipulated model, let an unchanged ribozyme $R$ perform $R+S⟶R+P$ on a separate substrate $S$. Assume the effective law of mass action $dS/dt=-kRS$, no reverse reaction, no ribozyme loss and no inhibited or long-lived bound states. Set $R=R_0$, $S(0)=5R_0$, $P(0)=0$ and $\tau =k{R}_{0}t$. Then $S/R_0=5e^{-\tau }$ and $P/R_0=5(1-e^{-\tau })$, with $S+P=5R_0$. At $\tau =1$, self-processing gives about $0.632$ completed events per initial RNA, whereas the regenerated ribozyme gives about $3.161$ reaction product molecules per initial ribozyme. More than one substrate conversion per initial ribozyme, with appropriate background and identity controls, is evidence for turnover. Product accumulation below that threshold alone cannot distinguish a reusable catalyst from one-shot chemistry. These models illustrate that distinction; actual enzyme kinetics can include folding delays, binding, saturation and product release.

A second messenger is a small intracellular molecule or ion that relays a received signal to target proteins. Its production, release, removal or binding changes its availability after signal reception. For a cell-surface receptor, distinguish the extracellular ligand, often called the first messenger, from the intracellular second messenger. An activated relay protein is not thereby a second messenger: the term identifies small chemical mediators, rather than every downstream component of signal transduction. ^[ref]

Two examples clarify what changes. A biological cell can make cAMP from ATP; alternatively, release of stored calcium ions can raise the free calcium concentration in its cytoplasm. The latter need not increase the total calcium content of the biological cell. Availability to target proteins, not merely the total amount present, carries the message. Removal and sequestration help terminate such signals. ^{[ref] [ref]}

The experimental motivation is unusually tangible: can a hormone's effect be transferred to machinery that barely responds to the hormone itself? In Rall, Sutherland and Berthet's 1957 experiment, washed cat-liver particles were incubated with ATP and magnesium ions, with or without epinephrine and glucagon, two hormones. After five minutes at $30{}^{\circ }\mathrm{C}$, the mixtures were heated in boiling water for three minutes, chilled, and separated to remove insoluble material. Small samples of the clarified extracts were transferred to a separate soluble dog-liver preparation, again supplied with ATP and magnesium ions. The readout was the change in glycogen phosphorylase activity over five minutes, not the amount of newly synthesized protein. ^[ref]

The hormone-conditioned extract caused a larger increase in glycogen phosphorylase activity. Water, extract made without hormones, and hormones added directly to the soluble preparation produced smaller effects. These comparisons distinguish transferred activity from baseline activity, preparation effects and simple hormone carryover. ^[ref]

The inference is a transferable, heat-stable intermediary between the hormone-sensitive particles and the soluble machinery. This does not identify the intermediary merely from heat resistance, establish its direct target, or show that every hormone uses the same mechanism. Rall and Sutherland's 1958 paper reports the factor's identification as cAMP in accompanying chemical work, and follows its production from ATP. It also reports an important limit: washed heart and skeletal-muscle particles produced detectable cAMP with epinephrine under their test conditions, whereas brain particles produced similar amounts with and without it. Tissue and preparation matter. ^[ref]

The useful and beautiful separation is between recognition and execution: an extracellular ligand can control intracellular enzymes through a chemically different intermediary. Making many second messenger molecules can support signal amplification, while different target proteins give the same mediator different consequences. A second messenger identifies a mode of relaying information; its presence alone does not specify the size or direction of the response. ^[ref]

Signal amplification is an increase in a specified downstream response relative to an initiating signal. In a molecular-count description, one activated component can generate or activate many downstream molecules. Repeated catalysis by an enzyme supplies a mechanism: the enzyme remains available for another chemical reaction. Successive stages can multiply the response. For a biological example, Cooper describes the epinephrine-to-glycogen phosphorylase pathway, where production of many cAMP molecules and repeated downstream protein phosphorylation provide opportunities for signal amplification. This is an example, not a claim that every signal transduction pathway has the same stages or gain. ^[ref]

Here is a counting toy extending the example under signal transduction. Suppose $N_0$ activated receptors each activate $a=5$ distinct relay proteins during a first interval. During a subsequent interval, each relay activates $b=20$ distinct target proteins. Assume enough inactive relays and targets, no shared targets, and no loss of activity during the count. ThenFor $N_0=1$, this gives $N_1=5$ and $N_2=100$: the target-to-receptor count ratio is $100$. These are assumed integer counts, not measured rates or a universal physiological amplification factor. The intervals are sequential; the equations do not specify a time course.

Availability limits the multiplication. As a second toy assumption, let there be only $T=250$ initially inactive target proteins shared by all branches, and suppose the branches can activate distinct targets until this pool is exhausted. ThenTwo activated receptors give $200$ active targets, whereas three give $250$, not $300$. At three activated receptors, the total count ratio is $250/3\simeq 83.3$; adding a fourth activates no additional targets. Thus total output per input and the increment caused by an extra input are different notions of gain. This finite-pool rule is an illustrative bound, not an enzyme kinetics law.

Signal amplification makes a small initiating signal capable of a larger response, but it does not supply the material or energy for downstream chemical reactions. In the second messenger transfer experiment, both stages still required added ATP and magnesium ions. Counts, changes in concentration, and changes in enzyme activity are different readouts; an amplification claim should name its input, output and observation interval. ^[ref]